Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy

Surgery-induced stress and anesthesia-related immunosuppression are believed to play a critical role in human oncology patients. Studies have hypothesized that anesthesia influences patients' outcome, promoting tumor recurrence and metastasis. Aim of the study was to investigate whether anesthe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eugenio Faroni, Silvia Sabattini, Jacopo Lenzi, Dina Guerra, Stefano Comazzi, Luca Aresu, Alessia Mazzanti, Stefano Zanardi, Veronica Cola, Emilio Lotito, Laura Marconato
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
dog
Acceso en línea:https://doaj.org/article/f720dc286db749d0b6ef1d26cf40d179
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f720dc286db749d0b6ef1d26cf40d179
record_format dspace
spelling oai:doaj.org-article:f720dc286db749d0b6ef1d26cf40d1792021-11-22T05:04:38ZSleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy2297-176910.3389/fvets.2021.760603https://doaj.org/article/f720dc286db749d0b6ef1d26cf40d1792021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.760603/fullhttps://doaj.org/toc/2297-1769Surgery-induced stress and anesthesia-related immunosuppression are believed to play a critical role in human oncology patients. Studies have hypothesized that anesthesia influences patients' outcome, promoting tumor recurrence and metastasis. Aim of the study was to investigate whether anesthesia promoted relapse in dogs with diffuse large B-cell lymphoma (DLBCL). Medical records were searched for dogs with DLBCL, that were in complete remission (CR) after the same chemo-immunotherapy protocol. Dogs receiving anesthesia were included if the procedure was performed while in CR. Time to relapse (TTR) was obtained via Kaplan–Meier method. Association between anesthesia and relapse was assessed using a nested case-control design and estimated using conditional logistic regression. Sixty-one dogs with DLBCL were included. Overall median TTR was 329 days (95% CI, 281–377). Forty-eight (79%) dogs relapsed during the study period, while 13 (21%) were still in CR at data analysis closure. Eighteen (30%) dogs received anesthesia with opioids, propofol, and isoflurane or sevoflurane. The relative risk of lymphoma relapse for dogs undergoing anesthesia was significantly higher compared with dogs not undergoing anesthesia, with an odds ratio of 3.09 (P = 0.019) on multivariable analysis. Anesthesia may promote relapse in dogs with DLBCL treated with chemo-immunotherapy, although a role of perioperative stress cannot be ultimately excluded. Considering the high frequency of anesthetic procedures required for diagnostic and therapeutic protocols among oncology patients, it is of utmost interest to characterize the effects of single anesthetic agents on the immune system. Further prospective studies are needed to better define the impact of anesthesia on patients' outcome.Eugenio FaroniSilvia SabattiniJacopo LenziDina GuerraStefano ComazziLuca AresuAlessia MazzantiStefano ZanardiVeronica ColaEmilio LotitoLaura MarconatoFrontiers Media S.A.articleanesthesiadogimmunosuppressionlymphomapropofolTIVAVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic anesthesia
dog
immunosuppression
lymphoma
propofol
TIVA
Veterinary medicine
SF600-1100
spellingShingle anesthesia
dog
immunosuppression
lymphoma
propofol
TIVA
Veterinary medicine
SF600-1100
Eugenio Faroni
Silvia Sabattini
Jacopo Lenzi
Dina Guerra
Stefano Comazzi
Luca Aresu
Alessia Mazzanti
Stefano Zanardi
Veronica Cola
Emilio Lotito
Laura Marconato
Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
description Surgery-induced stress and anesthesia-related immunosuppression are believed to play a critical role in human oncology patients. Studies have hypothesized that anesthesia influences patients' outcome, promoting tumor recurrence and metastasis. Aim of the study was to investigate whether anesthesia promoted relapse in dogs with diffuse large B-cell lymphoma (DLBCL). Medical records were searched for dogs with DLBCL, that were in complete remission (CR) after the same chemo-immunotherapy protocol. Dogs receiving anesthesia were included if the procedure was performed while in CR. Time to relapse (TTR) was obtained via Kaplan–Meier method. Association between anesthesia and relapse was assessed using a nested case-control design and estimated using conditional logistic regression. Sixty-one dogs with DLBCL were included. Overall median TTR was 329 days (95% CI, 281–377). Forty-eight (79%) dogs relapsed during the study period, while 13 (21%) were still in CR at data analysis closure. Eighteen (30%) dogs received anesthesia with opioids, propofol, and isoflurane or sevoflurane. The relative risk of lymphoma relapse for dogs undergoing anesthesia was significantly higher compared with dogs not undergoing anesthesia, with an odds ratio of 3.09 (P = 0.019) on multivariable analysis. Anesthesia may promote relapse in dogs with DLBCL treated with chemo-immunotherapy, although a role of perioperative stress cannot be ultimately excluded. Considering the high frequency of anesthetic procedures required for diagnostic and therapeutic protocols among oncology patients, it is of utmost interest to characterize the effects of single anesthetic agents on the immune system. Further prospective studies are needed to better define the impact of anesthesia on patients' outcome.
format article
author Eugenio Faroni
Silvia Sabattini
Jacopo Lenzi
Dina Guerra
Stefano Comazzi
Luca Aresu
Alessia Mazzanti
Stefano Zanardi
Veronica Cola
Emilio Lotito
Laura Marconato
author_facet Eugenio Faroni
Silvia Sabattini
Jacopo Lenzi
Dina Guerra
Stefano Comazzi
Luca Aresu
Alessia Mazzanti
Stefano Zanardi
Veronica Cola
Emilio Lotito
Laura Marconato
author_sort Eugenio Faroni
title Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
title_short Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
title_full Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
title_fullStr Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
title_full_unstemmed Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
title_sort sleeping beauty: anesthesia may promote relapse in dogs with diffuse large b-cell lymphoma in complete remission after chemo-immunotherapy
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f720dc286db749d0b6ef1d26cf40d179
work_keys_str_mv AT eugeniofaroni sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT silviasabattini sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT jacopolenzi sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT dinaguerra sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT stefanocomazzi sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT lucaaresu sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT alessiamazzanti sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT stefanozanardi sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT veronicacola sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT emiliolotito sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
AT lauramarconato sleepingbeautyanesthesiamaypromoterelapseindogswithdiffuselargebcelllymphomaincompleteremissionafterchemoimmunotherapy
_version_ 1718418198153396224